153 related articles for article (PubMed ID: 34563755)
21. Nuclear Enriched Abundant Transcript 1 (NEAT1): A long non-coding RNA with diverse functions in tumorigenesis.
Ghafouri-Fard S; Taheri M
Biomed Pharmacother; 2019 Mar; 111():51-59. PubMed ID: 30576934
[TBL] [Abstract][Full Text] [Related]
22. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth.
Huang JZ; Chen M; Chen D; Gao XC; Zhu S; Huang H; Hu M; Zhu H; Yan GR
Mol Cell; 2017 Oct; 68(1):171-184.e6. PubMed ID: 28985503
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
Zhuang K; Wu Q; Jin CS; Yuan HJ; Cheng JZ
Cancer Biomark; 2016; 16(2):291-300. PubMed ID: 26756620
[TBL] [Abstract][Full Text] [Related]
24. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
25. HOX transcript antisense RNA: An oncogenic lncRNA in diverse malignancies.
Ghafouri-Fard S; Dashti S; Farsi M; Taheri M
Exp Mol Pathol; 2021 Feb; 118():104578. PubMed ID: 33238156
[TBL] [Abstract][Full Text] [Related]
26. DICER-AS1 lncRNA: A putative culprit in the pathogenesis of gastric cancer.
Afrough H; Ghafouri-Fard S; Yousefi H; Pakzad P; Kholghi Oskooei V; Taheri M
Exp Mol Pathol; 2020 Oct; 116():104490. PubMed ID: 32663487
[TBL] [Abstract][Full Text] [Related]
27. Silencing long non-coding RNA HNF1A-AS1 inhibits growth and resistance to TAM of breast cancer cells via the microRNA-363/SERTAD3 axis.
Li Y; Liu L; Lv Y; Zhang Y; Zhang L; Yu H; Tian W; Zhang Z; Cui S
J Drug Target; 2021 Aug; 29(7):742-753. PubMed ID: 33472456
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
Zhang G; An X; Zhao H; Zhang Q; Zhao H
Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA HNF1A-AS1 upregulates OTX1 to enhance angiogenesis in colon cancer via the binding of transcription factor PBX3.
Wu J; Meng X; Jia Y; Chai J; Wang J; Xue X; Dang T
Exp Cell Res; 2020 Aug; 393(2):112025. PubMed ID: 32325080
[TBL] [Abstract][Full Text] [Related]
30. UCA1 long non-coding RNA: An update on its roles in malignant behavior of cancers.
Ghafouri-Fard S; Taheri M
Biomed Pharmacother; 2019 Dec; 120():109459. PubMed ID: 31585301
[TBL] [Abstract][Full Text] [Related]
31. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic roles of lncRNA BLACAT1 and its related mechanisms in human cancers.
Han W; Yu F; Guan W
Biomed Pharmacother; 2020 Oct; 130():110632. PubMed ID: 34321169
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation‑mediated decrease of lncRNA HNF1A‑AS1 contributes to malignant progression of laryngeal squamous cell carcinoma via EMT.
Shi Y; Zhang Q; Xie M; Feng Y; Ma S; Yi C; Wang Z; Li Y; Liu X; Liu H; Yang H; Yan Y; Zhang Y; Ren X; Luo H
Oncol Rep; 2020 Dec; 44(6):2503-2516. PubMed ID: 33125127
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNAs in cancer: mechanisms of action and technological advancements.
Bartonicek N; Maag JL; Dinger ME
Mol Cancer; 2016 May; 15(1):43. PubMed ID: 27233618
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte nuclear factor 1A (HNF1A) as a possible tumor suppressor in pancreatic cancer.
Luo Z; Li Y; Wang H; Fleming J; Li M; Kang Y; Zhang R; Li D
PLoS One; 2015; 10(3):e0121082. PubMed ID: 25793983
[TBL] [Abstract][Full Text] [Related]
37. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53.
Li H; Jiang X; Niu X
Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611
[TBL] [Abstract][Full Text] [Related]
38. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer.
Wang J; Su Z; Lu S; Fu W; Liu Z; Jiang X; Tai S
Clin Chim Acta; 2018 Oct; 485():229-233. PubMed ID: 29981289
[TBL] [Abstract][Full Text] [Related]
39. Myocardial Infarction Associated Transcript (MIAT): Review of its impact in the tumorigenesis.
Ghafouri-Fard S; Azimi T; Taheri M
Biomed Pharmacother; 2021 Jan; 133():111040. PubMed ID: 33378948
[TBL] [Abstract][Full Text] [Related]
40. The HASTER lncRNA promoter is a cis-acting transcriptional stabilizer of HNF1A.
Beucher A; Miguel-Escalada I; Balboa D; De Vas MG; Maestro MA; Garcia-Hurtado J; Bernal A; Gonzalez-Franco R; Vargiu P; Heyn H; Ravassard P; Ortega S; Ferrer J
Nat Cell Biol; 2022 Oct; 24(10):1528-1540. PubMed ID: 36202974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
